Cystic Fibrosis Screening Using the College Panel: Platform Comparison and Lessons Learned from the First 20,000 Samples
Overview
Authors
Affiliations
Purpose: To determine the accuracy of two commercially available kits for cystic fibrosis (CF) genotyping and determine allele frequencies for the ACMG/ACOG recommended mutations.
Methods: A total of 1,040 consecutive analyses using Roche CF Gold Strips and the ABI CF Genotyper were performed. Subsequently we performed analyses of 20,103 samples.
Results: Both kits accurately determined CF genotypes. The I148T mutation was found >100 times more frequently in carrier screening than in CF patients. Asymptomatic patients were identified who are compound heterozygotes for delta F508 and I148T. Four of 13 patients heterozygous for delta F508 and the IVS8-5T polymorphism had some symptoms of CF.
Conclusion: Accurate and timely analysis can be performed for the ACMG CF panel. I148T is a low penetrance CF allele.
Phenotyping Rare CFTR Mutations Reveal Functional Expression Defects Restored by TRIKAFTA.
Laselva O, Ardelean M, Bear C J Pers Med. 2021; 11(4).
PMID: 33920764 PMC: 8071105. DOI: 10.3390/jpm11040301.
Wilfond B, Goddard K Mol Genet Genomic Med. 2015; 3(4):239-42.
PMID: 26247041 PMC: 4521960. DOI: 10.1002/mgg3.130.
Schwartz K, Pike-Buchanan L, Muralidharan K, Redman J, Amos Wilson J, Jarvis M J Mol Diagn. 2009; 11(3):211-5.
PMID: 19324992 PMC: 2671338. DOI: 10.2353/jmoldx.2009.080106.
Strom C, Janeszco R, Quan F, Wang S, Buller A, McGinniss M J Mol Diagn. 2006; 8(3):371-5.
PMID: 16825511 PMC: 1867610. DOI: 10.2353/jmoldx.2006.050115.
Detection of an apparent homozygous 3120G>A cystic fibrosis mutation on a routine carrier screen.
Heaney D, Flume P, Hamilton L, Lyon E, Wolff D J Mol Diagn. 2006; 8(1):137-40.
PMID: 16436646 PMC: 1867569. DOI: 10.2353/jmoldx.2006.050065.